PHYLLODULCIN PROTECTS PC12 CELLS AGAINST THE INJURY INDUCED BY OXYGEN AND GLUCOSE DEPRIVATION-RESTORATION

被引:2
|
作者
Hu, Chang-Long [1 ]
Ge, Lu [2 ]
Tang, Yong [1 ]
Li, Jie [1 ]
Wu, Chun-Hui [1 ]
Hu, Jiang-Hong [2 ]
Yuan, Jin-Tao [1 ]
Fan, Yong-Zhong [1 ]
机构
[1] Peoples Hosp Danyang, Dept Neurosurg, Danyang 212300, Jiangsu, Peoples R China
[2] Peoples Hosp Danyang, Dept Gastroenterol, Danyang 212300, Jiangsu, Peoples R China
来源
ACTA POLONIAE PHARMACEUTICA | 2019年 / 76卷 / 06期
关键词
phyllodulcin; PC12; cells; oxygen and glucose deprivation/restoration; apoptosis; oxidative stress; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; APOPTOSIS; INHIBITION; PATHWAYS; LEAVES;
D O I
10.32383/appdr/112045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Phyllodulcin is a natural coumarin derivative found in Hydrangea macrophylla. To discover effective therapeutics for cerebral ischemia-reperfusion injury, we investigated the protective effects of phyllodulcin on PC12 cells injury induced by oxygenation and glucose deprivation/restoration (OGD/R). As a result, phyllodulcin can improve the cell viability and attenuate the extracellular lactate dehydrogenase release. Meanwhile, phyllodulcin can ameliorate the dysfunction of mitochondria by reducing reactive oxygen species production. decreasing the intracellular calcium level and increasing the mitochondrial membrane potential. ROS-associaled OGD/R can induce cell apoptosis through the mitochondrial pathway. Phyllodulcin can inhibit apoptosis of PC12 cells through down-regulation of Caspase-3 and flax as well as up-regulation of Bcl-2. These results indicate phyllodukin can protect PC12 cells against the damage induced by OGD/R. This investigation gives promising evidences for the therapy of cerebral ischemia-reperfusion injury.
引用
收藏
页码:1043 / 1050
页数:8
相关论文
共 50 条
  • [21] Protodioscin protects PC12 cells against oxygen and glucose deprivation-induced injury through miR-124/AKT/Nrf2 pathway
    Shu, Kun
    Zhang, Yuelin
    CELL STRESS & CHAPERONES, 2019, 24 (06): : 1091 - 1099
  • [22] Protective effect of Hibiscus sabdariffa against serum/glucose deprivation-induced PC12 cells injury
    Bakhtiari, Elham
    Hosseini, Azar
    Mousavi, Seyed Hadi
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2015, 5 (03) : 231 - 237
  • [23] Deep hypothermia-enhanced autophagy protects PC12 cells against oxygen glucose deprivation via a mitochondrial pathway
    Tang, Dang
    Wang, Cheng
    Gao, Yongjun
    Pu, Jun
    Long, Jiang
    Xu, Wei
    NEUROSCIENCE LETTERS, 2016, 632 : 79 - 85
  • [24] LncRNA ANRIL protects against oxygen and glucose deprivation (OGD)-induced injury in PC-12 cells: potential role in ischaemic stroke
    Liu, Bin
    Gao, Wei
    Xue, Jian
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 1384 - 1395
  • [25] SULFATED PACHYMARAN PROTECTS PC12 CELLS AGAINST MPP+-INDUCED INJURY
    Gao, Gui-Zhen
    Wu, Chao
    Xue, Hong-Yu
    Shan, Ling-Ling
    Meng, Qing-Zhen
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2016, 14 (02) : 127 - 132
  • [26] Neuroglobin protects PC12 cells against β-amyloid-induced cell injury
    Li, Richard C.
    Pouranfar, Farzan
    Lee, Seung Kwan
    Morris, Matthew W.
    Wang, Yang
    Gozal, David
    NEUROBIOLOGY OF AGING, 2008, 29 (12) : 1815 - 1822
  • [27] Puerarin protects PC12 cells against β-amyloid-induced cell injury
    Zhang, Hai-Ying
    Liu, Yi-Heng
    Wang, Hong-Quan
    Xu, Jie-Hua
    Hu, Hai-Tao
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (10) : 1230 - 1237
  • [28] Mast cell-derived mediators protect against oxygen-glucose deprivation-induced injury in PC12 cells and neurons
    Hu, Weiwei
    Fan, Yanyin
    Shen, Yao
    Yang, Yuzhe
    Dai, Haibin
    Fu, Qiull
    Chen, Zhong
    NEUROSCIENCE LETTERS, 2007, 423 (01) : 35 - 40
  • [29] Protective effects of the knockdown of lncRNA AK139328 against oxygen glucose deprivation/reoxygenation-induced injury in PC12 cells
    Liu, Liyan
    Zheng, Bin
    Wang, Zhaoxia
    MOLECULAR MEDICINE REPORTS, 2021, 24 (03)
  • [30] On PC12 oxygen glucose deprivation and cell death
    Vavilis, Theofanis
    Kritis, Aristeidis
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 104 : 849 - 850